New York, July 22, 2021 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Global Digital Pathology Systems Industry” – https://www.reportlinker.com/p05205340/?utm_source=GNW
9 Million in the year 2020, is projected to reach a revised size of US$1.4 Billion by 2027, growing at a CAGR of 13.9% over the analysis period 2020-2027.Device, one of the segments analyzed in the report, is projected to grow at a 13.8% CAGR to reach US$753.1 Million by the end of the analysis period.After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Software segment is readjusted to a revised 14.6% CAGR for the next 7-year period. This segment currently accounts for a 29.2% share of the global Digital Pathology Systems market.
The U.S. Accounts for Over 42.1% of Global Market Size in 2020, While China is Forecast to Grow at a 15.1% CAGR for the Period of 2020-2027
The Digital Pathology Systems market in the U.S. is estimated at US$241.7 Million in the year 2020. The country currently accounts for a 42.12% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$114.2 Million in the year 2027 trailing a CAGR of 15.1% through 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 10.9% and 12.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 12.8% CAGR while Rest of European market (as defined in the study) will reach US$114.2 Million by the year 2027.
Other Segments Segment Corners a 17.8% Share in 2020
In the global Other Segments segment, USA, Canada, Japan, China and Europe will drive the 12.7% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$86.6 Million in the year 2020 will reach a projected size of US$200.3 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$68.5 Million by the year 2027, while Latin America will expand at a 12.5% CAGR through the analysis period.
Select Competitors (Total 74 Featured)
- 3DHISTECH Ltd.
- Apollo Enterprise Imaging Corp.
- Carl Zeiss AG
- Corista LLC
- Glencoe Software, Inc
- Hamamatsu Photonics K.K.
- Huron Digital Pathology, Inc.
- Indica Labs
- Inspirata Inc
- KANTERON SYSTEMS S.L.U
- KONFOONG BIOTECH INTERNATIONAL CO.,LTD
- Leica Biosystems Nussloch GmbH
- MikroScan Technologies
- Inc.
- Objective Pathology Services
- Olympus Corporation
- OptraSCAN, Inc
- Philips Healthcare
- Proscia Inc
- Sectra AB
- Visiopharm A/S
Read the full report: https://www.reportlinker.com/p05205340/?utm_source=GNW
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
COVID-19 Ushers in 2020 as the Year of Healthcare Digitalization
EXHIBIT 1: Global Venture Capital Investments in Digital Health
Startups (In US$ Billion)
EXHIBIT 2: % Share VC Investments by Category for 2020
FDA Temporarily Relaxes Guidelines to Promote Remote Digital
Pathology Services amid COVID-19 Pandemic
COVID-19 Highlights Need to Implement Structured Online
Curriculum for Pathology Training
Future Outlook of Pathology Post-COVID-19
Digital Pathology: An Introduction
Key Digital Pathology Tools
Market Outlook
US and Europe Maintain Dominance
Emerging Markets to Experience Strong Growth
Scanners Lead Digital Pathology Market
Software Segment Post Strong Growth
Disease Diagnosis: Major Application of Digital Pathology Systems
Telepathology Experiences Strong Growth
Pharmaceutical and Biotechnology Companies: Important End Use
Markets for Digital Pathology
EXHIBIT 3: Global Digital Pathology Systems Market by End-Use:
2020
Major Issues Hampering Adoption of Digital Pathology Systems
Competitive Landscape
EXHIBIT 4: Market Share of Leading Players in Digital Pathology
Systems Market: 2020E
Recent Market Activity
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Technological Advancements Drive Adoption of Digital Pathology
Systems
Artificial Intelligence (AI) Steps in to Widen the Scope & Span
of Digital Pathology
EXIBIT: AI Spending in Healthcare & Lifesciences in US$ Million
for Years 2020 & 2025
Advantages of AI-Powered Digital Pathology
Digital Pathology Benefits Drug Discovery Process
Need for Early Diagnosis Puts Focus on Digital Pathology
Digital Pathology Systems See Fast Paced Adoption in Cancer and
Other Chronic Diseases
EXHIBIT 5: Global Cancer Incidence: Number of New Cancer Cases
in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
EXHIBIT 6: Number of New Cancer Cases and Deaths (in Million)
by Region for 2018
EXHIBIT 7: Global New Cancer Cases and Cancer-related Deaths by
Cancer Site (in %) for 2018
Digital Pathology Emerges as a Tool to Reduce Cases of Cancer
Misdiagnoses
Scarcity of Pathologists & Excess Workload on Pathology Labs
Drives Demand for Digital Systems
Clinical Research Continues to be Core Vertical for Digital
Pathology
Digital Imaging and Robotic Light Microscopy Boost Growth
Computational Pathology for Leading-Edge Image Analytics
Cloud Platform Gains Momentum
Telepathology Expected to Pave Way for Pathology Outsourcing to
Developing Nations
Rise in Significance of Personalized Medicine Bodes Well for
Digital Pathology
EXHIBIT 8: Global Personalized Medicine Market: Revenues in US$
Million for the Years 2019 and 2024
Increased Focus on Companion Diagnostics to Benefit Market Growth
Improving Healthcare & Research Expenditure to Support Growth
EXHIBIT 9: World Healthcare Expenditure (In US$ Billion) for
the Years 2017-2023
Aging Population: A Key Opportunity Indicator
EXHIBIT 10: Global Aging Population: Population of 65+
Individuals (in Thousands) by Region for 2019 and 2030
EXHIBIT 11: Global Population of 65+ Individuals as % of Total
Population by Region for 2019 and 2030
EXHIBIT 12: Global Cancer Deaths by Age Group (in %) for 2019
Challenges Facing Digital Pathology Systems Market
High Costs
Workflow Integration with Other Related Functions
Other Issues
4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Digital Pathology
Systems by Geographic Region – USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR
Table 2: World Historic Review for Digital Pathology Systems by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2015 through 2019 and % CAGR
Table 3: World 12-Year Perspective for Digital Pathology
Systems by Geographic Region – Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa Markets for Years 2015,
2020 & 2027
Table 4: World Current & Future Analysis for Device by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 5: World Historic Review for Device by Geographic Region –
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets – Independent Analysis
of Annual Sales in US$ Thousand for Years 2015 through 2019 and
% CAGR
Table 6: World 12-Year Perspective for Device by Geographic
Region – Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2015, 2020 & 2027
Table 7: World Current & Future Analysis for Software by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 8: World Historic Review for Software by Geographic
Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets – Independent Analysis
of Annual Sales in US$ Thousand for Years 2015 through 2019 and
% CAGR
Table 9: World 12-Year Perspective for Software by Geographic
Region – Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2015, 2020 & 2027
Table 10: World Current & Future Analysis for Other Segments by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 11: World Historic Review for Other Segments by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2015 through 2019 and % CAGR
Table 12: World 12-Year Perspective for Other Segments by
Geographic Region – Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2015, 2020 & 2027
Table 13: World Current & Future Analysis for Human Pathology
by Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 14: World Historic Review for Human Pathology by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2015 through 2019 and % CAGR
Table 15: World 12-Year Perspective for Human Pathology by
Geographic Region – Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2015, 2020 & 2027
Table 16: World Current & Future Analysis for Veterinary
Pathology by Geographic Region – USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR
Table 17: World Historic Review for Veterinary Pathology by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2015 through 2019 and % CAGR
Table 18: World 12-Year Perspective for Veterinary Pathology by
Geographic Region – Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2015, 2020 & 2027
Table 19: World Current & Future Analysis for Pharma & Biotech
Companies by Geographic Region – USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR
Table 20: World Historic Review for Pharma & Biotech Companies
by Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2015 through 2019 and % CAGR
Table 21: World 12-Year Perspective for Pharma & Biotech
Companies by Geographic Region – Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2015, 2020 &
2027
Table 22: World Current & Future Analysis for Hospitals &
Reference Labs by Geographic Region – USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets – Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 and % CAGR
Table 23: World Historic Review for Hospitals & Reference Labs
by Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2015 through 2019 and % CAGR
Table 24: World 12-Year Perspective for Hospitals & Reference
Labs by Geographic Region – Percentage Breakdown of Value Sales
for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa for Years 2015, 2020 & 2027
Table 25: World Current & Future Analysis for Academic &
Research Institutes by Geographic Region – USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets – Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 and % CAGR
Table 26: World Historic Review for Academic & Research
Institutes by Geographic Region – USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2015 through 2019 and % CAGR
Table 27: World 12-Year Perspective for Academic & Research
Institutes by Geographic Region – Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2015, 2020 &
2027
III. MARKET ANALYSIS
UNITED STATES
COVID-19 Triggers Demand for Digital Pathology
Market Overview
Increasing Pressure on Pathological Labs: Cornerstone for Growth
Table 28: USA Current & Future Analysis for Digital Pathology
Systems by Segment – Device, Software and Other Segments –
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 29: USA Historic Review for Digital Pathology Systems by
Segment – Device, Software and Other Segments Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2015 through 2019 and % CAGR
Table 30: USA 12-Year Perspective for Digital Pathology Systems
by Segment – Percentage Breakdown of Value Sales for Device,
Software and Other Segments for the Years 2015, 2020 & 2027
Table 31: USA Current & Future Analysis for Digital Pathology
Systems by Type – Human Pathology and Veterinary Pathology –
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 32: USA Historic Review for Digital Pathology Systems by
Type – Human Pathology and Veterinary Pathology Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2015 through 2019 and % CAGR
Table 33: USA 12-Year Perspective for Digital Pathology Systems
by Type – Percentage Breakdown of Value Sales for Human
Pathology and Veterinary Pathology for the Years 2015, 2020 &
2027
Table 34: USA Current & Future Analysis for Digital Pathology
Systems by End-Use – Pharma & Biotech Companies, Hospitals &
Reference Labs and Academic & Research Institutes – Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 35: USA Historic Review for Digital Pathology Systems by
End-Use – Pharma & Biotech Companies, Hospitals & Reference
Labs and Academic & Research Institutes Markets – Independent
Analysis of Annual Sales in US$ Thousand for Years 2015 through
2019 and % CAGR
Table 36: USA 12-Year Perspective for Digital Pathology Systems
by End-Use – Percentage Breakdown of Value Sales for Pharma &
Biotech Companies, Hospitals & Reference Labs and Academic &
Research Institutes for the Years 2015, 2020 & 2027
CANADA
Table 37: Canada Current & Future Analysis for Digital
Pathology Systems by Segment – Device, Software and Other
Segments – Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR
Table 38: Canada Historic Review for Digital Pathology Systems
by Segment – Device, Software and Other Segments Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2015 through 2019 and % CAGR
Table 39: Canada 12-Year Perspective for Digital Pathology
Systems by Segment – Percentage Breakdown of Value Sales for
Device, Software and Other Segments for the Years 2015, 2020 &
2027
Table 40: Canada Current & Future Analysis for Digital
Pathology Systems by Type – Human Pathology and Veterinary
Pathology – Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 41: Canada Historic Review for Digital Pathology Systems
by Type – Human Pathology and Veterinary Pathology Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2015 through 2019 and % CAGR
Table 42: Canada 12-Year Perspective for Digital Pathology
Systems by Type – Percentage Breakdown of Value Sales for Human
Pathology and Veterinary Pathology for the Years 2015, 2020 &
2027
Table 43: Canada Current & Future Analysis for Digital
Pathology Systems by End-Use – Pharma & Biotech Companies,
Hospitals & Reference Labs and Academic & Research Institutes –
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 44: Canada Historic Review for Digital Pathology Systems
by End-Use – Pharma & Biotech Companies, Hospitals & Reference
Labs and Academic & Research Institutes Markets – Independent
Analysis of Annual Sales in US$ Thousand for Years 2015 through
2019 and % CAGR
Table 45: Canada 12-Year Perspective for Digital Pathology
Systems by End-Use – Percentage Breakdown of Value Sales for
Pharma & Biotech Companies, Hospitals & Reference Labs and
Academic & Research Institutes for the Years 2015, 2020 & 2027
JAPAN
Market Overview
Table 46: Japan Current & Future Analysis for Digital Pathology
Systems by Segment – Device, Software and Other Segments –
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 47: Japan Historic Review for Digital Pathology Systems
by Segment – Device, Software and Other Segments Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2015 through 2019 and % CAGR
Table 48: Japan 12-Year Perspective for Digital Pathology
Systems by Segment – Percentage Breakdown of Value Sales for
Device, Software and Other Segments for the Years 2015, 2020 &
2027
Table 49: Japan Current & Future Analysis for Digital Pathology
Systems by Type – Human Pathology and Veterinary Pathology –
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 50: Japan Historic Review for Digital Pathology Systems
by Type – Human Pathology and Veterinary Pathology Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2015 through 2019 and % CAGR
Table 51: Japan 12-Year Perspective for Digital Pathology
Systems by Type – Percentage Breakdown of Value Sales for Human
Pathology and Veterinary Pathology for the Years 2015, 2020 &
2027
Table 52: Japan Current & Future Analysis for Digital Pathology
Systems by End-Use – Pharma & Biotech Companies, Hospitals &
Reference Labs and Academic & Research Institutes – Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 53: Japan Historic Review for Digital Pathology Systems
by End-Use – Pharma & Biotech Companies, Hospitals & Reference
Labs and Academic & Research Institutes Markets – Independent
Analysis of Annual Sales in US$ Thousand for Years 2015 through
2019 and % CAGR
Table 54: Japan 12-Year Perspective for Digital Pathology
Systems by End-Use – Percentage Breakdown of Value Sales for
Pharma & Biotech Companies, Hospitals & Reference Labs and
Academic & Research Institutes for the Years 2015, 2020 & 2027
CHINA
Market Overview
Table 55: China Current & Future Analysis for Digital Pathology
Systems by Segment – Device, Software and Other Segments –
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 56: China Historic Review for Digital Pathology Systems
by Segment – Device, Software and Other Segments Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2015 through 2019 and % CAGR
Table 57: China 12-Year Perspective for Digital Pathology
Systems by Segment – Percentage Breakdown of Value Sales for
Device, Software and Other Segments for the Years 2015, 2020 &
2027
Table 58: China Current & Future Analysis for Digital Pathology
Systems by Type – Human Pathology and Veterinary Pathology –
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 59: China Historic Review for Digital Pathology Systems
by Type – Human Pathology and Veterinary Pathology Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2015 through 2019 and % CAGR
Table 60: China 12-Year Perspective for Digital Pathology
Systems by Type – Percentage Breakdown of Value Sales for Human
Pathology and Veterinary Pathology for the Years 2015, 2020 &
2027
Table 61: China Current & Future Analysis for Digital Pathology
Systems by End-Use – Pharma & Biotech Companies, Hospitals &
Reference Labs and Academic & Research Institutes – Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 62: China Historic Review for Digital Pathology Systems
by End-Use – Pharma & Biotech Companies, Hospitals & Reference
Labs and Academic & Research Institutes Markets – Independent
Analysis of Annual Sales in US$ Thousand for Years 2015 through
2019 and % CAGR
Table 63: China 12-Year Perspective for Digital Pathology
Systems by End-Use – Percentage Breakdown of Value Sales for
Pharma & Biotech Companies, Hospitals & Reference Labs and
Academic & Research Institutes for the Years 2015, 2020 & 2027
EUROPE
Market Overview
Table 64: Europe Current & Future Analysis for Digital
Pathology Systems by Geographic Region – France, Germany,
Italy, UK, Spain, Russia and Rest of Europe Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 65: Europe Historic Review for Digital Pathology Systems
by Geographic Region – France, Germany, Italy, UK, Spain,
Russia and Rest of Europe Markets – Independent Analysis of
Annual Sales in US$ Thousand for Years 2015 through 2019 and %
CAGR
Table 66: Europe 12-Year Perspective for Digital Pathology
Systems by Geographic Region – Percentage Breakdown of Value
Sales for France, Germany, Italy, UK, Spain, Russia and Rest of
Europe Markets for Years 2015, 2020 & 2027
Table 67: Europe Current & Future Analysis for Digital
Pathology Systems by Segment – Device, Software and Other
Segments – Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR
Table 68: Europe Historic Review for Digital Pathology Systems
by Segment – Device, Software and Other Segments Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2015 through 2019 and % CAGR
Table 69: Europe 12-Year Perspective for Digital Pathology
Systems by Segment – Percentage Breakdown of Value Sales for
Device, Software and Other Segments for the Years 2015, 2020 &
2027
Table 70: Europe Current & Future Analysis for Digital
Pathology Systems by Type – Human Pathology and Veterinary
Pathology – Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 71: Europe Historic Review for Digital Pathology Systems
by Type – Human Pathology and Veterinary Pathology Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2015 through 2019 and % CAGR
Table 72: Europe 12-Year Perspective for Digital Pathology
Systems by Type – Percentage Breakdown of Value Sales for Human
Pathology and Veterinary Pathology for the Years 2015, 2020 &
2027
Table 73: Europe Current & Future Analysis for Digital
Pathology Systems by End-Use – Pharma & Biotech Companies,
Hospitals & Reference Labs and Academic & Research Institutes –
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 74: Europe Historic Review for Digital Pathology Systems
by End-Use – Pharma & Biotech Companies, Hospitals & Reference
Labs and Academic & Research Institutes Markets – Independent
Analysis of Annual Sales in US$ Thousand for Years 2015 through
2019 and % CAGR
Table 75: Europe 12-Year Perspective for Digital Pathology
Systems by End-Use – Percentage Breakdown of Value Sales for
Pharma & Biotech Companies, Hospitals & Reference Labs and
Academic & Research Institutes for the Years 2015, 2020 & 2027
FRANCE
Table 76: France Current & Future Analysis for Digital
Pathology Systems by Segment – Device, Software and Other
Segments – Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR
Table 77: France Historic Review for Digital Pathology Systems
by Segment – Device, Software and Other Segments Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2015 through 2019 and % CAGR
Table 78: France 12-Year Perspective for Digital Pathology
Systems by Segment – Percentage Breakdown of Value Sales for
Device, Software and Other Segments for the Years 2015, 2020 &
2027
Table 79: France Current & Future Analysis for Digital
Pathology Systems by Type – Human Pathology and Veterinary
Pathology – Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 80: France Historic Review for Digital Pathology Systems
by Type – Human Pathology and Veterinary Pathology Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2015 through 2019 and % CAGR
Table 81: France 12-Year Perspective for Digital Pathology
Systems by Type – Percentage Breakdown of Value Sales for Human
Pathology and Veterinary Pathology for the Years 2015, 2020 &
2027
Table 82: France Current & Future Analysis for Digital
Pathology Systems by End-Use – Pharma & Biotech Companies,
Hospitals & Reference Labs and Academic & Research Institutes –
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 83: France Historic Review for Digital Pathology Systems
by End-Use – Pharma & Biotech Companies, Hospitals & Reference
Labs and Academic & Research Institutes Markets – Independent
Analysis of Annual Sales in US$ Thousand for Years 2015 through
2019 and % CAGR
Table 84: France 12-Year Perspective for Digital Pathology
Systems by End-Use – Percentage Breakdown of Value Sales for
Pharma & Biotech Companies, Hospitals & Reference Labs and
Academic & Research Institutes for the Years 2015, 2020 & 2027
GERMANY
Table 85: Germany Current & Future Analysis for Digital
Pathology Systems by Segment – Device, Software and Other
Segments – Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR
Table 86: Germany Historic Review for Digital Pathology Systems
by Segment – Device, Software and Other Segments Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2015 through 2019 and % CAGR
Table 87: Germany 12-Year Perspective for Digital Pathology
Systems by Segment – Percentage Breakdown of Value Sales for
Device, Software and Other Segments for the Years 2015, 2020 &
2027
Table 88: Germany Current & Future Analysis for Digital
Pathology Systems by Type – Human Pathology and Veterinary
Pathology – Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 89: Germany Historic Review for Digital Pathology Systems
by Type – Human Pathology and Veterinary Pathology Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2015 through 2019 and % CAGR
Table 90: Germany 12-Year Perspective for Digital Pathology
Systems by Type – Percentage Breakdown of Value Sales for Human
Pathology and Veterinary Pathology for the Years 2015, 2020 &
2027
Table 91: Germany Current & Future Analysis for Digital
Pathology Systems by End-Use – Pharma & Biotech Companies,
Hospitals & Reference Labs and Academic & Research Institutes –
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 92: Germany Historic Review for Digital Pathology Systems
by End-Use – Pharma & Biotech Companies, Hospitals & Reference
Labs and Academic & Research Institutes Markets – Independent
Analysis of Annual Sales in US$ Thousand for Years 2015 through
2019 and % CAGR
Table 93: Germany 12-Year Perspective for Digital Pathology
Systems by End-Use – Percentage Breakdown of Value Sales for
Pharma & Biotech Companies, Hospitals & Reference Labs and
Academic & Research Institutes for the Years 2015, 2020 & 2027
ITALY
Table 94: Italy Current & Future Analysis for Digital Pathology
Systems by Segment – Device, Software and Other Segments –
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 95: Italy Historic Review for Digital Pathology Systems
by Segment – Device, Software and Other Segments Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2015 through 2019 and % CAGR
Table 96: Italy 12-Year Perspective for Digital Pathology
Systems by Segment – Percentage Breakdown of Value Sales for
Device, Software and Other Segments for the Years 2015, 2020 &
2027
Table 97: Italy Current & Future Analysis for Digital Pathology
Systems by Type – Human Pathology and Veterinary Pathology –
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 98: Italy Historic Review for Digital Pathology Systems
by Type – Human Pathology and Veterinary Pathology Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2015 through 2019 and % CAGR
Table 99: Italy 12-Year Perspective for Digital Pathology
Systems by Type – Percentage Breakdown of Value Sales for Human
Pathology and Veterinary Pathology for the Years 2015, 2020 &
2027
Table 100: Italy Current & Future Analysis for Digital
Pathology Systems by End-Use – Pharma & Biotech Companies,
Hospitals & Reference Labs and Academic & Research Institutes –
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 101: Italy Historic Review for Digital Pathology Systems
by End-Use – Pharma & Biotech Companies, Hospitals & Reference
Labs and Academic & Research Institutes Markets – Independent
Analysis of Annual Sales in US$ Thousand for Years 2015 through
2019 and % CAGR
Table 102: Italy 12-Year Perspective for Digital Pathology
Systems by End-Use – Percentage Breakdown of Value Sales for
Pharma & Biotech Companies, Hospitals & Reference Labs and
Academic & Research Institutes for the Years 2015, 2020 & 2027
UNITED KINGDOM
Table 103: UK Current & Future Analysis for Digital Pathology
Systems by Segment – Device, Software and Other Segments –
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 104: UK Historic Review for Digital Pathology Systems by
Segment – Device, Software and Other Segments Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2015 through 2019 and % CAGR
Table 105: UK 12-Year Perspective for Digital Pathology Systems
by Segment – Percentage Breakdown of Value Sales for Device,
Software and Other Segments for the Years 2015, 2020 & 2027
Table 106: UK Current & Future Analysis for Digital Pathology
Systems by Type – Human Pathology and Veterinary Pathology –
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 107: UK Historic Review for Digital Pathology Systems by
Type – Human Pathology and Veterinary Pathology Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2015 through 2019 and % CAGR
Table 108: UK 12-Year Perspective for Digital Pathology Systems
by Type – Percentage Breakdown of Value Sales for Human
Pathology and Veterinary Pathology for the Years 2015, 2020 &
2027
Table 109: UK Current & Future Analysis for Digital Pathology
Systems by End-Use – Pharma & Biotech Companies, Hospitals &
Reference Labs and Academic & Research Institutes – Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 110: UK Historic Review for Digital Pathology Systems by
End-Use – Pharma & Biotech Companies, Hospitals & Reference
Labs and Academic & Research Institutes Markets – Independent
Analysis of Annual Sales in US$ Thousand for Years 2015 through
2019 and % CAGR
Table 111: UK 12-Year Perspective for Digital Pathology Systems
by End-Use – Percentage Breakdown of Value Sales for Pharma &
Biotech Companies, Hospitals & Reference Labs and Academic &
Research Institutes for the Years 2015, 2020 & 2027
SPAIN
Table 112: Spain Current & Future Analysis for Digital
Pathology Systems by Segment – Device, Software and Other
Segments – Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR
Table 113: Spain Historic Review for Digital Pathology Systems
by Segment – Device, Software and Other Segments Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2015 through 2019 and % CAGR
Table 114: Spain 12-Year Perspective for Digital Pathology
Systems by Segment – Percentage Breakdown of Value Sales for
Device, Software and Other Segments for the Years 2015, 2020 &
2027
Table 115: Spain Current & Future Analysis for Digital
Pathology Systems by Type – Human Pathology and Veterinary
Pathology – Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 116: Spain Historic Review for Digital Pathology Systems
by Type – Human Pathology and Veterinary Pathology Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2015 through 2019 and % CAGR
Table 117: Spain 12-Year Perspective for Digital Pathology
Systems by Type – Percentage Breakdown of Value Sales for Human
Pathology and Veterinary Pathology for the Years 2015, 2020 &
2027
Table 118: Spain Current & Future Analysis for Digital
Pathology Systems by End-Use – Pharma & Biotech Companies,
Hospitals & Reference Labs and Academic & Research Institutes –
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 119: Spain Historic Review for Digital Pathology Systems
by End-Use – Pharma & Biotech Companies, Hospitals & Reference
Labs and Academic & Research Institutes Markets – Independent
Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p05205340/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.
__________________________
